SNDX icon

Syndax Pharmaceuticals
SNDX

Overview Fund Activity

123 hedge funds and large institutions have $938M invested in Syndax Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
+8
Holders Change %
+6.96%
% of All Funds
2.16%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
20
Increased
38
Reduced
40
Closed
12
Calls
$894K
Puts
$389K
Net Calls
+$505K
Net Calls Change
+$1.18M

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$22.3M
2
SI
2
Sofinnova Investments
California
$7.91M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$54.8M
4
WP
4
Woodline Partners
California
$11.1M
5
Barclays
5
Barclays
United Kingdom
$7.69M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$29.5M
2
State Street
2
State Street
Massachusetts
$40.2M
3
Goldman Sachs
3
Goldman Sachs
New York
$6.12M
4
HM
4
HealthCor Management
New York
$23.2M
5
GTC
5
Ghost Tree Capital
New York
$11M
Name Holding Trade Value Shares
Change 		Shares
Change %
Northern Trust
26
Northern Trust
Illinois
$8.76M -$14.5K -761 -0.2%
PAI
27
Palo Alto Investors
California
$8.5M +$837K +43,800 +11%
SI
28
Sofinnova Investments
California
$7.91M +$7.91M +413,841 New
Barclays
29
Barclays
United Kingdom
$7.69M +$6.59M +345,050 +602%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$6.53M -$1.65M -86,600 -20%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$6.44M -$1.4M -73,321 -18%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$6.38M +$4.32M +225,948 +209%
Goldman Sachs
33
Goldman Sachs
New York
$6.12M -$14.5M -756,660 -70%
VC
34
Vivo Capital
California
$6.12M – – –
Charles Schwab
35
Charles Schwab
California
$5.78M +$629K +32,896 +12%
Lord, Abbett & Co
36
Lord, Abbett & Co
New Jersey
$5.56M -$71.9K -3,765 -1%
Morgan Stanley
37
Morgan Stanley
New York
$4.84M +$3.9M +204,243 +418%
PF
38
Phoenix Financial
Israel
$4.01M +$1.91M +100,000 +91%
ACP
39
Acuta Capital Partners
California
$3.94M – – –
PAM
40
Panagora Asset Management
Massachusetts
$3.9M -$34.8K -1,820 -0.9%
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$3.8M +$2.72M +142,484 +254%
O
42
OrbiMed
New York
$3.64M +$3.64M +190,600 New
Macquarie Group
43
Macquarie Group
Australia
$3.46M – – –
Nuveen Asset Management
44
Nuveen Asset Management
Illinois
$3.46M -$836K -42,244 -19%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$3.22M +$409K +21,405 +15%
BBA
46
Baker Bros. Advisors
New York
$2.12M +$2.12M +110,729 New
Two Sigma Investments
47
Two Sigma Investments
New York
$2.1M -$45.1K -2,359 -2%
ACM
48
Altium Capital Management
New York
$2.06M +$2.06M +108,000 New
GTCM
49
Gyon Technologies Capital Management
New Jersey
$1.77M +$1.77M +92,385 New
Bank of America
50
Bank of America
North Carolina
$1.72M +$1.1M +57,340 +175%
1
2
3 4 5